Clock

What Has to Happen, and Roughly When

The re-rating path here is calendar-driven, not sentiment-driven. Fiserv's own second-half 2026 bridge adds about 7 points of adjusted revenue growth, roughly half of it from a non-recurring comparison that simply lapses [1]. Consensus places the first year-over-year earnings growth in the September 2026 quarter. Against that, the drawdown has no precedent in 36 years of the name's own price history, and the leadership executing the plan changed twice in the last eight weeks.

The Mechanism That Closes the Gap

Four things are in motion, and they can be separated by how much new demand each one requires.

1. The non-recurring comparison lapses — 2H 2026

Fiserv's 2025 revenue carried an unusually large slug of non-recurring items, concentrated in the first half. Management has quantified what happens when that base rolls off: first-half 2026 adjusted revenue growth in the low single digits, second-half growth of 6% to 8% or better [2]. The bridge between the two halves is disclosed component by component.

memory access out of bounds

Source: 2026 Investor Day, Visibility Into the Drivers of 2026 [3].

The largest single piece — about 3.5 of the roughly 7 points — requires nothing of the underlying business except that it holds. The remaining 3.5 points require contracted revenue to convert, volumes to ramp and new products to sell. On the first-quarter call the CFO said the second quarter would be the trough in the year-over-year revenue decline, with a return to "a much more normalized growth picture in the back half" helped by a comparative tailwind in Financial Solutions from third-quarter 2025 actions and by contracted revenue from named client wins [4]. The window is the third-quarter print (late October 2026) and the fourth-quarter print (February 2027).

2. Cost normalization and a named efficiency programme — 2H 2026 into 2029

The margin path is guided on the same calendar: adjusted operating margin of approximately 31% to 32% in the first half of 2026, 35% to 36% in the second half, with the fourth quarter the high point, and roughly 34% for the full year [5]. Beyond 2026, Project Elevate targets a reduction of more than $500 million in 2029 run-rate costs, worth an incremental 200 basis points or more of adjusted operating margin [6], inside a medium-term frame of 37% or better by 2029 [7].

3. Guidance resetting against a bar the company set low itself

The bar was reset in one step, not several. February 2025 guidance was 10% to 12% organic revenue growth and $10.10 to $10.30 of adjusted EPS [8]. On 29 October 2025 that became 3.5% to 4% organic growth and $8.50 to $8.60 of adjusted EPS [9]. The 2026 guide of 1% to 3% adjusted revenue growth and $8.00 to $8.30 adjusted EPS [10] is therefore a guided decline against the $8.64 actually delivered in 2025. Management describes 2026 as a transition year [11]. It has now been reaffirmed twice: at the first-quarter print on 5 May 2026 [12] and again on 15 June 2026 alongside the change of chief executive [13].

The medium-term algorithm published on 14 May 2026 is 4% to 6% adjusted revenue growth from 2026 to 2029 with annual double-digit adjusted EPS growth [14], landing at more than $23 billion of adjusted revenue, more than $13.5 billion of cumulative free cash flow across 2027–2029, and adjusted EPS greater than $12 in 2029 [15]. That $13.5 billion of three-year cash flow is 44% of the $30.6 billion market capitalisation at the 29 July 2026 close of $55.67.

4. Buybacks shrinking the denominator — throttled by the leverage target

Guidance is for a weighted-average share count of approximately 530 million in 2026, against 547.1 million basic weighted-average shares in FY2025 — a reduction of about 3.1% [16]. The pace, however, is set by the balance sheet rather than by the yield. Fiserv repurchased 3.3 million shares for approximately $200 million in the first quarter of 2026 while finishing the quarter at gross leverage below 3.2x and targeting approximately 3.0x at year-end; the CFO framed capital return around "managing our leverage ratio" [17]. Annualised, that first-quarter pace is roughly $800 million, or 2.6% of the market capitalisation, against consensus 2026 free cash flow of $3.88 billion — about one-fifth of cash flow going to repurchase in the year when the yield on that cash flow is 12.7%. The medium-term commitment is that a majority of free cash flow goes to buybacks while the company targets the low end of a 2.5x–3.0x leverage range [18] [19], which places the flywheel after the deleveraging, not alongside it. The maturity and covenant detail sits in Self-Help.

The event that could fail to happen

Two overhangs have dates attached rather than moods. Jana Partners disclosed a stake in February 2026 and pressed for board changes and asset sales [20]; the announced divestiture of ATM Managed Services, Cash and Logistics, and MoneyPass to Bridgeport Partners — about $200 million of 2025 revenue, $275–$300 million of after-tax cash proceeds plus a 49% joint-venture interest — is that agenda converting into cash [21]. The securities class action over Clover migration disclosures, with a class period running July 2024 to July 2025, remains undated as to resolution [22].

The counterweight: who is executing this

Michael Lyons resigned as chief executive and director on 12 June 2026, effective immediately, after roughly seventeen months; Takis Georgakopoulos was appointed chief executive on 14 June 2026 [23]. On 7 July 2026 Dhivya Suryadevara resigned as President for good reason, and the Financial Solutions business — the segment whose revenue declined 6% organically in the first quarter [24] — was handed to two interim leaders [25]. The second-half acceleration and the 2029 algorithm were authored in May 2026 by a management team that no longer holds three of its senior seats. The promise-versus-delivery record of the prior team is the relevant prior: 10% to 12% organic growth guided in February 2025 became 3.5% to 4% eight months later [26] [27].

The Catalyst Calendar

memory access out of bounds

Sources: Q2 2026 date confirmed by the company on 14 July 2026 [28]; later dates are indicative, projected from the reporting pattern of the last two years (Q3 2025 reported 29 October 2025, FY2025 reported 10 February 2026) and are not company-confirmed.

What Consensus Expects, and When

Consensus has the recovery arriving in printed numbers in the September 2026 quarter. The second quarter reporting on 6 August is expected to be the low point.

memory access out of bounds

Source: reported figures and forward consensus means from the run's consensus estimate data, as of 30 July 2026; quarterly reported adjusted EPS also appears in the corresponding results presentations.

Year over year, the sequence is specific. Second-quarter 2026 consensus of $1.92 is 22% below the $2.47 printed a year earlier. Third-quarter consensus of $2.16 is 5.9% above the $2.04 reported on 29 October 2025 — the first positive comparison. Fourth-quarter consensus of $2.27 is 14.3% above $1.99. On revenue the same shape holds: consensus of $5,155 million and $5,181 million for the third and fourth quarters against $4,919 million and $4,900 million a year earlier, or 5.3% growth across the second half.

That 5.3% sits below the company's own 6% to 8%-or-better second-half bridge [29]. The street is underwriting the comparison effect and discounting part of the execution. The candidate quarter is the third quarter of 2026, reported in late October 2026 — the first period in which the direction of travel reverses in a printed number rather than in a slide.

One arithmetic caution on the near-term line: first-quarter 2026 adjusted EPS of $1.79 included a $0.17 benefit from an 11% effective tax rate driven by a valuation-allowance release, against full-year guidance of 19% to 19.5% [30]. First-quarter 2027 consensus of $1.77 therefore reads as a decline against a reported base that was flattered by roughly seventeen cents of timing.

Street positioning

Source: consensus recommendations and target prices from the run's consensus estimate data, as of 30 July 2026; percentages derived from 36 in-consensus recommendations.

Of 36 in-consensus recommendations, 25 are holds, 6 are buys, 3 outperform, 1 underperform and 1 sell — a consensus recommendation score of 2.67. The mean target price of $66.63 across 27 estimates is 19.7% above the 29 July close of $55.67; the median of $63.00 is 13.2% above it. The high and low targets are $115 and $40, a dispersion of nearly 3:1 that is itself a statement about how little agreement there is on the earnings base.

This is a sell side that has moved to the sidelines rather than one that has capitulated. Only 5.6% of ratings are negative, but only 25% are positive, and the mean target implies a share price 72% below the March 2025 peak. Estimate revisions have not yet turned: the FY2027 adjusted EPS mean has drifted from $9.15 six months ago to $8.93 now, a 2.4% reduction, and the FY2027 revenue mean from $20,978 million to $20,854 million. The out-year is firmer — FY2028 EPS has risen from $9.75 to $10.02 over the same six months — which is consistent with the street marking the margin and buyback algorithm to the Investor Day while still trimming the near term.

memory access out of bounds

Source: consensus free cash flow and adjusted EPS means from the run's consensus estimate data as of 30 July 2026; yields derived against the $30.56 billion market capitalisation at the 29 July 2026 close of $55.67 on 549.0 million shares.

Consensus itself carries a forward free cash flow yield of 12.7% on 2026 and 14.0% on 2027, and the 2029 EPS mean of $11.62 sits about 3% below the company's stated "greater than $12" target [31] — the street is close to underwriting the medium-term algorithm, without the top of it. The yield computation against the framework's bar is worked in Yield.

Base Rates From This Name's Own History

Fiserv's daily price record runs from January 1990. Across 36 years there are seven drawdowns of 30% or more measured close to close from a running peak. Six completed; the seventh is live.

memory access out of bounds

Source: derived from daily closing prices, 2 January 1990 to 29 July 2026, in the run's price history; split-adjusted closes, running-peak method, 30% threshold.

memory access out of bounds

Source: derived from daily closing prices, 2 January 1990 to 29 July 2026, in the run's price history; depth is trough close divided by peak close minus one, durations are calendar months between the dated closes. The 1990 closes are $0.6557 and $0.4390 split-adjusted and display rounded to two decimals.

The arithmetic a skeptic can recompute: 47.18 / 237.79 − 1 = −80.16%, over 476 calendar days from 3 March 2025 to 22 June 2026, or 15.6 months. The median depth of the six completed episodes is 38.0%; this one is 2.1 times that, and 1.56 times the deepest prior episode (−51.5% in 2002). The current episode has no precedent in the name's own 36-year price history — the base rates below describe a different animal and should be weighted accordingly.

memory access out of bounds

Source: derived from daily closing prices, 2 January 1990 to 29 July 2026, in the run's price history; the 2025 episode has no recovery leg yet.

Two readings come out of the completed six. Full round trips — peak back to peak — took a median of 19.8 months and a mean of 23.4 months, but the distribution is bimodal: the four shallower episodes (30% to 38%) round-tripped in 5.8 to 26.4 months, while the two episodes deeper than 50% took 40.8 and 42.3 months. Partial re-rating came far faster. Measured from trough to a 50% gain off the trough, the six episodes took 1.6, 1.9, 2.8, 7.1, 8.2 and 17.8 months — a median of about 5 months. As of 29 July 2026 the stock is already 18.0% above the 22 June trough, five weeks after it.

The relevant scale, though, is set by the depth. A full round trip from the 22 June trough requires a 404% gain; from the 29 July close of $55.67 it requires 327%. A 50% gain off the trough — the milestone that historically arrived in a median of five months — lands at $70.77, still 70% below the March 2025 peak and 6% above the current mean street target of $66.63. Both of the name's genuinely deep drawdowns (2002, 2007–08) were market-wide events with market-wide recoveries; this one is company-specific, which removes the market's own repair from the mechanism and puts the whole burden on the printed numbers. The anatomy of the decline, including the 7.4x volume spike in the peak-to-trough leg, is worked in Dislocation, and the question of how much of the fall reflects permanent damage is in Damage Math.

The 18-Month Test

On the evidence above, re-recognition of the earnings base within 18 to 24 months is a reasonable expectation; re-recognition of the 2025 valuation is not, and no part of the record supports it on that clock.

The supporting arithmetic is that the near-term mechanism is largely a comparison effect rather than a demand recovery: roughly 3.5 of the approximately 7 points of second-half 2026 acceleration comes from the non-recurring headwind lapsing [32], and consensus places the first positive year-over-year quarter in September 2026, three months out. An 18-month window from 31 July 2026 runs to about the end of January 2028 and contains six quarterly prints plus two annual guidance events, including the first guided year of the 2027–2029 algorithm. A 24-month window adds the completed FY2027 result, reported around February 2028 — the first evidence that would confirm or break the algorithm rather than describe it.

The strongest fact against the read is the execution risk sitting on top of it. Three of the senior seats authoring the plan turned over between June and July 2026 [33] [34], and the prior team's February-to-October 2025 guidance path shows what this company's forward numbers have been worth [35] [36]. Sell-side revisions for FY2027 are still drifting down, not up.

What would falsify the read, in the falsifier ledger's terms: second-half 2026 adjusted revenue growth printing below the low-single-digit first-half trend instead of the guided 6% to 8% or better; a third cut to the $8.00–$8.30 adjusted EPS guide; or repurchases staying near the first quarter's $200 million pace through 2027 while free cash flow runs near $3.9 billion, which would confirm that capital allocation has pivoted to deleveraging for the duration of the window.

The Instrument Facts

Stated as facts, with their sources and dates. No part of this section is a recommendation.

Listed equity options on FISV exist and include expiries beyond twelve months. As of 30–31 July 2026, the option chain published by Stock Options Channel runs from weekly expiries through 21 January 2028, which is the longest listed expiry at 540 days, or approximately 17.7 months. Intermediate long-dated expiries include 15 January 2027, 19 March 2027 and 17 June 2027.

Liquidity at the long end is present but concentrated. Barchart's chain for the 21 January 2028 expiry, as of 30 July 2026, shows total open interest of 56,112 call contracts and 16,487 put contracts — 72,599 contracts on that single expiry — against that day's volume of 399 calls and 85 puts. Near-dated activity is heavier: Stock Options Channel reported 10,883 call and 3,632 put contracts traded on 30 July 2026 across all expiries.

On implied volatility, three dated readings:

• 30-day mean implied volatility of 0.5607, or 56.1%, for 29 July 2026 (AlphaQuery, FISV volatility and option statistics).
• 120-day mean implied volatility of 0.4860, or 48.6%, for 29 July 2026 (AlphaQuery, FISV volatility and option statistics).
• At-the-money implied volatility of 46.98% on the 21 January 2028 expiry, with an IV rank of 57.40% and 36.31% historic volatility, as of 30 July 2026 (Barchart, FISV options).

Against the framework's reference lines — up to roughly 50–55 acceptable, 60–70 elevated — the 30-day reading of 56.1% sits just above the acceptable band, and the earnings release scheduled for 6 August 2026 falls inside that 30-day window [37]. The two long-dated readings, 48.6% at 120 days and 47.0% at the January 2028 expiry, sit inside the band. The term structure is downward-sloping, with the 30-day reading 9.1 points above the January 2028 expiry's at-the-money level.

One duration fact matters for the framework's own 18-month reference: the longest listed expiry, 21 January 2028, is 17.7 months from 31 July 2026 and falls approximately three weeks before Fiserv would be expected to report full-year 2027 results — the first completed year of the 2027–2029 algorithm — on the February pattern of the last two years (FY2025 results were reported on 10 February 2026). Longer-dated January 2029 contracts are not listed as of 31 July 2026; whether and when they are listed is a decision of the exchanges, not the company.